China will refine its drug pricing system with 14 measures, Xinhua reports
Importance
Level 1
- The plan includes optimising launch pricing for innovative and newly listed drugs
- Will use payment standards to guide pricing, encouraging reasonable pharmacy retail prices, strengthening supply and price stability for shortage medicines, and enhancing monitoring, enforcement, audit oversight and drug value assessment to keep prices within a reasonable range.